ATL-301

N/A

Report date: 2025/03/10 15:00:00
NME

Base Information

Drug NameATL-301
Drug Alias NameATL-301
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionSodium channel protein type IX alpha subunit modulators
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsTrigeminal Neuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtalanta Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAtalanta Therapeutics
Inactive CompaniesN/A
Active IndicationsTrigeminal Neuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A